Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 33OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1

Interventions

Vinorelbine 3Gemcitabine 3Ifosfamide 2Cyclophosphamide 2zanubrutinib 1treosulfan 1plerixafor 1pegylated granulocyte colony-stimulating factor 1obinutuzumab 1ibritumomab tiuxetan 1fludarabine 1entecavir 1Thiotepa 1Rituximab 1Ice 1Guanosine Diphosphate 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1EPOCH protocol 1Drug Therapy 1Cytarabine 1CVAD protocol 11-(1-glycero)dodeca-1,3,5,7,9-pentaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Lymphoma, Non-Hodgkin × Thiotepa × Clear all
NCT02507479 2016-04-20

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Sheba Medical Center

Phase 2 Unknown
24 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡